Breathing Therapy
Conditions
Keywords
Breathing Therapy, Schizophrenia patients, Sleep, Fatigue
Brief summary
This study aimed to determine the effects of breathing therapies on sleep disturbances and fatigue in patients with schizophrenia.The study will be conducted at a CMHC in Ağrı province between May and August 2021. At the CMHC, community-based mental health services are provided to patients with severe mental disorders (schizophrenia, bipolar disorder) who are in remission as assessed by a psychiatrist. The study is planned to be conducted with patients who meet the study criteria, without using a sample selection method. Patients over the age of 18 registered with CMHC and followed with a diagnosis of schizophrenia were contacted by phone and invited to CMHC. The study was conducted with patients who met the inclusion criteria and agreed to participate. Data will be collected using the Descriptive Characteristics Form, the DSM-5 Sleep Disorder Scale, and the Brief Fatigue Inventory. The experimental group received eight sessions of respiratory therapy.The control group received no intervention. The study sample size was calculated using the GPower computer program. A power analysis performed at α=0.05 revealed an effect size of 150.153 (d=0.8), providing 90% power. Therefore, it was calculated that a minimum of 68 patients should be included in the sample.
Detailed description
Study data were collected by the researcher through face-to-face interviews. The study included individuals diagnosed with schizophrenia who met the inclusion criteria (registration in a CMHC, having a diagnosis of schizophrenia, willingness to participate in the study, and openness to communication and collaboration). Pre-test measurement instruments were administered to the participants. The experimental group received eight sessions of respiratory therapy. The control group received no intervention. Post-test data were collected following the training sessions.
Interventions
OTHERSession 8: Evaluation
\*Reinforcing what has been learned. \*Evaluating the program. \*Obtaining feedback
OTHERSession 1: Preparation Session
\*Meeting Patients \*Introducing the Content of Psychoeducation \*Emphasizing the Importance of Regular and Timely Attendance at Training \*Determining Training Dates \*Sharing Individuals' Experiences and Expectations
OTHERSession 2: Recognizing the Illness
\*What is Schizophrenia? \*What are its Symptoms? \*What Does Treatment Include?
OTHERSession 3: Treatment Evaluation
\*Things to Consider When Using Medication \*Side Effects of Medication \*Exacerbation of Schizophrenia \*Precursor Symptoms.
OTHERSession 4: What is anger?
\*What are the symptoms of anger? \*What are the methods for coping with anger?
OTHERSession 5: Communication
\*What is communication? \*The importance of communication. \*Fundamentals of communication, working on I language. \*Ways to prevent communication difficulties.
OTHERSession 6: What is relaxation?
What is progressive relaxation? Introducing a relaxation CD
OTHERSession 7: Relaxation
Practicing the relaxation CD with patients
Sponsors
Ataturk University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes
Inclusion criteria
* Being registered with a CMHC * Being diagnosed with schizophrenia * Being between the ages of 18 and 60 * Being willing to participate in the study * Being open to communication and cooperation * Being in remission
Exclusion criteria
* Not being open to communication and cooperation
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Personal Information Form | up to 1 day | It consists of a total of 8 questions (age, gender, marital status, education level, duration of illness, income status, family history of mental illness and employment status) created by the researcher in the light of literature and includes the sociodemographic characteristics of the patients. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| DSM-5 Sleep Disorder Scale | up to 1 day | The DSM-5 Sleep Disorder Adult Scale Short Form is an eight-item scale that assesses sleep disturbances in individuals aged 18 and older. The scale is designed to be completed by the individual before a clinician's consultation. Each item asks the patient (or an informed person) to rate the severity of their sleep disturbance over the past seven days. The scale's validity and reliability in Turkish were conducted by Yüzeren et al. in 2017. |
Other
| Measure | Time frame | Description |
|---|---|---|
| Brief Fatigue Inventory | up to 1 day | Developed by Mendoza and colleagues at the M.D. Anderson Cancer Center in 1999, the scale consists of 10 questions. The form assesses general fatigue levels (fatigue felt at the time of the interview, general fatigue experienced within the last 24 hours, and the worst fatigue level experienced within the last 24 hours) and the degree to which daily activities (general activity, mood, walking ability, life outside the home, communication with others, and joy of life) have been affected by fatigue in the last 24 hours. The arithmetic mean of the scores given for these first three questions is calculated to obtain each individual's fatigue score. The Cronbach's α value for the original scale, developed by Mendoza and colleagues (1999), was found to be 0.96. |
Countries
Turkey (Türkiye)
Outcome results
None listed